GLIOSIS side effect
What is GLIOSIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
GLIOSIS and Recently Reported Side Effects
GLIOSIS and 15 most Active Side Effect polls
GLIOSIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with GLIOSIS
BEVACIZUMAB GLIADEL INTERFERON NATALIZUMAB NORDITROPIN PROGRAF TAMIFLU TYSABRIInterferon Side Effects Report #5473225-4
Physician from GERMANY reported INTERFERON ALFA problem on Sept 18, 2007. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: gliosis, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PARACETAMOL, ATACAND, ZOMETA, MOVICOL, NEDOLON. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5476189-2
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 18, 2007. Male patient, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gliosis, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALPHA, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized and became disabled. Patient recovered.
Interferon Side Effects Report #5480372-X
Physician from GERMANY reported INTERFERON ALFA problem on Sept 27, 2007. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: gliosis, radiation injury, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5482905-6
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 27, 2007. Male patient, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gliosis, irritability, weight decreased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALPHA, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized and became disabled. Patient recovered.
Interferon Side Effects Report #5288259-2
Physician from GERMANY reported INTERFERON ALFA problem on Mar 30, 2007. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: gliosis, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized. Patient recovered.
Interferon Side Effects Report #5290996-0
INTERFERON ALFA problem was reported by a Physician from GERMANY on Apr 03, 2007. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: gliosis, . INTERFERON ALFA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5297725-5
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Apr 03, 2007. Male patient, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gliosis, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALPHA, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5630009-1
TYSABRI problem was reported by a Physician from GERMANY on Jan 29, 2008. Female patient, 20 years of age, weighting 132.3 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: fatigue, gliosis, haematoma, headache, malaise, nausea, oral herpes, quadriparesis, skin discolouration, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5573147-4
Physician from GERMANY reported NATALIZUMAB problem on Dec 11, 2007. Female patient, 20 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: fatigue, gliosis, haematoma, headache, nausea, oral herpes, quadriparesis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5506352-3
NATALIZUMAB problem was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, 20 years of age, weighting 132.3 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: fatigue, gliosis, haematoma, headache, malaise, nausea, oral herpes, quadriparesis, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Tamiflu Side Effects Report #5343967-X
Physician from JAPAN reported TAMIFLU problem on May 22, 2007. Male patient, child 3 years of age, weighting 29.76 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: brain oedema, gliosis, nervous system disorder, pulmonary oedema, respiratory arrest, . TAMIFLU dosage: DOSE REPORTED AS 27.5 MG/2 MG/KG. Patient died on 12/16/2002.
Norditropin Side Effects Report #5368630-0
NORDITROPIN NORDIFLEX problem was reported by a Health Professional from UNITED STATES on June 21, 2007. Male patient, child 10 years of age, weighting 97.66 lb, was diagnosed with growth hormone deficiency and was treated with NORDITROPIN NORDIFLEX. After drug was administered, patient experienced the following problems/side effects: brain mass, gliosis, inflammation, nervous system disorder, . NORDITROPIN NORDIFLEX dosage: 2 MG QD SQ. During the same period patient was treated with HUMATROPE. Patient was hospitalized. Patient recovered.
Gliadel Side Effects Report #5475340-8
Physician from UNITED STATES reported GLIADEL problem on Dec 11, 2006. Female patient was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: brain abscess, brain neoplasm, gliosis, implant site reaction, necrosis, . GLIADEL dosage: unknown. Patient recovered.
Prograf Side Effects Report #5759381-9
PROGRAF problem was reported by a Physician from JAPAN on May 22, 2008. Female patient, 68 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: encephalitis herpes, encephalitis protozoal, gliosis, pneumonia, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, ACYCLOVIR, FOSCARNET. Patient died.
Bevacizumab Side Effects Report #5293620-6
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Mar 30, 2007. Male patient, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dyskinesia, gait disturbance, gliosis, hemiparesis, speech disorder, strabismus, weight decreased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALPHA, PARACETAMOL, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized. Patient recovered.